Browse Tag
Iambic Therapeutics
1 Article
Daily News
Elucid has raised $55 Million in New Series D Funding
Forus has raised $150 Million in New Series C Funding
Executive Change: Alterome Therapeutics Inc. Appoints Johanna Mylet as Chief Financial Officer
Executive Change: Algolia Appoints Steven Chung as Chief Revenue Officer
05
Oct
Iambic Therapeutics has filed a notice of an exempt offering of securities to raise $66,500,000.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Iambic...
